Search results for "Rigaku Analytical Devices"

The 1290 Infinity III Bio LC System is a UHPLC, binary or quaternary, consisting of biocompatible material for use in biopharma (e.g., critical quality attributes, such as Bio SEC) and other applications utilizing high salt and extreme pH conditions. Biocompatibility ensures the integrity of your biomolecules and robustness of the system.

Twist's cfDNA Pan-Cancer Reference Standard v2 provides researchers with high-quality, synthetic reference materials to assess and validate liquid biopsy assays, enhancing the detection of low-frequency cancer associated variants.

Microstructural ‘fingerprints’ of inhalation powders revealed by AI image analysis could help scientists develop better treatments for asthma

Discover insights on topics from lab automation to immuno-oncology, DNA printing technology, toxicology, and more

For a chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new products which have made the most difference to clinical diagnostics

Cast your vote for the product that has had the biggest impact on your research to be in with a chance of winning a $500 Amazon Gift Card (or equivalent currency)

For a chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new products which have made the most difference to clinical diagnostics

Peak Proteins' expertise in protein crystallography will enhance Sygnature Discovery’s fragment screening and analysis activities as well as its structure-based drug design capabilities

Watch this on-demand webinar to find out how you can streamline residual solvent analysis according to USP

This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers

Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment

The system is now in daily use at CaroMont Regional Medical Center

Innovation and growth remain a priority to support customers and COVID-19 initiatives

This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency

The award money will help to expand Nanotrap Particle manufacturing capacity for COVID-19 testing